Hangzhou Tigermed Consulting Balance Sheet Health
Financial Health criteria checks 5/6
Hangzhou Tigermed Consulting has a total shareholder equity of CN¥24.4B and total debt of CN¥3.7B, which brings its debt-to-equity ratio to 15.2%. Its total assets and total liabilities are CN¥30.3B and CN¥5.9B respectively. Hangzhou Tigermed Consulting's EBIT is CN¥1.3B making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥2.0B.
Key information
15.2%
Debt to equity ratio
CN¥3.71b
Debt
| Interest coverage ratio | -4.6x |
| Cash | CN¥2.04b |
| Equity | CN¥24.42b |
| Total liabilities | CN¥5.86b |
| Total assets | CN¥30.28b |
Recent financial health updates
Recent updates
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk
Aug 21
Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568
Jul 12Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?
Jun 26An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued
Jun 07Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 28Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Apr 08Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues
Apr 04Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
Apr 01Financial Position Analysis
Short Term Liabilities: 300347's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥4.8B).
Long Term Liabilities: 300347's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 300347's net debt to equity ratio (6.8%) is considered satisfactory.
Reducing Debt: 300347's debt to equity ratio has increased from 11.5% to 15.2% over the past 5 years.
Debt Coverage: 300347's debt is well covered by operating cash flow (28.5%).
Interest Coverage: 300347 earns more interest than it pays, so coverage of interest payments is not a concern.